Enbrel Gets Nod for Pediatric PsO; IL-33 Targeted in Itch

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Verrucous Psoriasis: A Rare Variant Refractory to Topical Steroids
Verrucous Psoriasis: A Rare Variant Refractory to Topical Steroids
Psoriasis
Verrucous Psoriasis: A Rare Variant Refractory to Topical Steroids
- George Jeha, MD
- Deborah Hilton, MD
- Maria Bao-Loc-Trung, BS
In The Pipeline: Phase 1, 2, and 3
In The Pipeline: Phase 1, 2, and 3
Psoriasis
In The Pipeline: Phase 1, 2, and 3
The Latest on Systemic Agents for Psoriasis: A Q&A With Jashin J. Wu, MD, FAAD
The Latest on Systemic Agents for Psoriasis: A Q&A With Jashin J. Wu, MD, FAAD
Psoriasis
The Latest on Systemic Agents for Psoriasis: A Q&A With Jashin J. Wu, MD, FAAD
- Jashin J. Wu, MD, FAAD
Psleep: Psoriasis and Sleep
Psleep: Psoriasis and Sleep
Psoriasis
Psleep: Psoriasis and Sleep
- Annelies Isabelle Johanna Groen
- Jennifer Cather, MD